31.
S2632 Challenge a Diverticular Bleeding
Asheikh, Mira; Andrawes, Sherif; Chehab, Hamed
The American journal of gastroenterology,
10/2022, Letnik:
117, Številka:
10S
Journal Article
Dostopno za:
UL
32.
Dostopno za:
UL
33.
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
Bretthauer, Michael; Løberg, Magnus; Wieszczy, Paulina ...
The New England journal of medicine,
10/2022, Letnik:
387, Številka:
17
Journal Article
In this randomized trial involving 84,585 participants in Poland, Norway, and Sweden, the risk of colorectal cancer at 10 years was lower among those invited to undergo screening colonoscopy than ...
among those assigned to no screening.
več
Dostopno za:
CMK, UL
34.
Dostopno za:
UL
35.
Naroči gradivo
36.
Continuing Medical Education Questions: August 2020
Vega, Kenneth J
The American journal of gastroenterology,
2020-Aug-01, 2020-08-00, 20200801, Letnik:
115, Številka:
8
Journal Article
Article Title: State Of The Science On Quality Indicators For Colonoscopy And How To Achieve Them.
Dostopno za:
UL
37.
Dostopno za:
UL
38.
Dostopno za:
UL
39.
Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
Wolf, Andrew M.D.; Fontham, Elizabeth T.H.; Church, Timothy R. ...
CA: a cancer journal for clinicians,
July/August 2018, Letnik:
68, Številka:
4
Journal Article
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer ...
Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model‐recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high‐sensitivity stool‐based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average‐risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high‐sensitivity, guaiac‐based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250–281. © 2018 American Cancer Society.
več
Dostopno za:
UL, VSZLJ
40.
Dostopno za:
UL
PDF
